Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy

Figure 4

Representative examples of multifunctional nanoparticulate systems studied in vivo for cancer immunotherapy [43–50]: PLGA-Poly(lactide-o-glycolic acid), PBCA-Polybutyl cyanoacrylate, and P(MDS-co-CES)-A triblock polymer.